Robert Alexander Ingram - 16 Dec 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Reporting relationship: FORMER DIRECTOR
Issuer ticker: BDTX
Reported as of: 16 Dec 2022
Net transaction value: +$14,062
SEC form: 4
Accepted by SEC: 19 Dec 2022, 20:14:26 UTC
Prior SEC filing: 02 Dec 2022
Next SEC filing: 02 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Brent Hatzis-Schoch, Attorney-in-Fact

Key filing fact

Robert Alexander Ingram filed Form 4 for Black Diamond Therapeutics, Inc. (BDTX) on 19 Dec 2022.

Key facts

This page summarizes Robert Alexander Ingram's Form 4 filing for Black Diamond Therapeutics, Inc. (BDTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Dec 2022, 20:14.

Change

Previous filing in this sequence was filed on 02 Dec 2022.
Current net transaction value: +$14,062.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDTX transaction

Common Stock

Award

Transaction value: $14,062
Shares: +9,375
Change %: +28%
Price: $1.50
Shares after: 42,854
Date: 16 Dec 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert Alexander Ingram is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.

Footnote F2

The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022.

SEC remarks

This "Exit" Form 4 is voluntarily filed to report that the Reporting Person is no longer serving in the role as the Company's director, effective as of December 13, 2022, and therefore is no longer subject to Section 16 reporting. The grant included herein relates to compensation for the role of the Reporting Person as a director prior to his resignation.